Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Rodeghiero

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Blood|May 29, 2009
How I treat von Willebrand diseaseFrancesco Rodeghiero, Giancarlo Castaman, Alberto Tosetto
Hematology. American Society of Hematology. Education Program|December 17, 2009
Optimizing treatment of von Willebrand disease by using phenotypic and molecular dataFrancesco Rodeghiero, Giancarlo Castaman, Alberto Tosetto
Internal and Emergency Medicine|July 8, 2010
Treatment outcome in a cohort of young patients with polycythemia veraMarco Ruggeri, Silvia Finotto, Stefania Fortuna, et al.
American Journal of Hematology|September 28, 2010
Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several yearsMaurizio Frezzato, Ilaria Giaretta, Domenico Madeo, et al.
British Journal of Haematology|April 6, 2021
Thrombosis in immune thrombocytopenia - current status and future perspectivesDawn Swan, Adrian Newland, Francesco Rodeghiero, et al.
Annals of Internal Medicine|September 19, 2003
The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosisMarco Ruggeri, Alberto Tosetto, Maurizio Frezzato, et al.
British Journal of Haematology|July 20, 2004
Intraindividual consistency of the activated protein C resistance phenotypeAlberto Tosetto, Monica Simioni, Domenico Madeo, et al.
Best Practice & Research. Clinical Haematology|March 17, 2009
Thrombosis associated with angiogenesis inhibitorsFrancesca Elice, Francesco Rodeghiero, Anna Falanga, et al.
Thrombosis and Haemostasis|January 26, 2011
Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearanceGiancarlo Castaman, Alberto Tosetto, Augusto B Federici, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 11, 2013
A novel heterozygous missense mutation (His127Arg) in a family with inherited cross-reacting material positive factor XI deficiencyGiancarlo Castaman, Sofia H Giacomelli, Annarita Tagliaferri, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Blood|May 29, 2009
How I treat von Willebrand diseaseFrancesco Rodeghiero, Giancarlo Castaman, Alberto Tosetto
Hematology. American Society of Hematology. Education Program|December 17, 2009
Optimizing treatment of von Willebrand disease by using phenotypic and molecular dataFrancesco Rodeghiero, Giancarlo Castaman, Alberto Tosetto
Internal and Emergency Medicine|July 8, 2010
Treatment outcome in a cohort of young patients with polycythemia veraMarco Ruggeri, Silvia Finotto, Stefania Fortuna, et al.
American Journal of Hematology|September 28, 2010
Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several yearsMaurizio Frezzato, Ilaria Giaretta, Domenico Madeo, et al.
British Journal of Haematology|April 6, 2021
Thrombosis in immune thrombocytopenia - current status and future perspectivesDawn Swan, Adrian Newland, Francesco Rodeghiero, et al.
Annals of Internal Medicine|September 19, 2003
The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosisMarco Ruggeri, Alberto Tosetto, Maurizio Frezzato, et al.
British Journal of Haematology|July 20, 2004
Intraindividual consistency of the activated protein C resistance phenotypeAlberto Tosetto, Monica Simioni, Domenico Madeo, et al.
Best Practice & Research. Clinical Haematology|March 17, 2009
Thrombosis associated with angiogenesis inhibitorsFrancesca Elice, Francesco Rodeghiero, Anna Falanga, et al.
Thrombosis and Haemostasis|January 26, 2011
Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearanceGiancarlo Castaman, Alberto Tosetto, Augusto B Federici, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 11, 2013
A novel heterozygous missense mutation (His127Arg) in a family with inherited cross-reacting material positive factor XI deficiencyGiancarlo Castaman, Sofia H Giacomelli, Annarita Tagliaferri, et al.
Pageof 16